Back

mr. drs. K. (Harry) Oosterbaan

mr. drs. K. (Harry) Oosterbaan

Full Professor
mr. drs. K. (Harry) Oosterbaan
  • Department of Pulmonary Diseases

Biography

Biography

Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center  Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology. 

Side Activities

Chairman of the medical advisory board of the Dutch CF Foundation (NCFS)

Advisory board member Vertex Pharmaceuticals (2019)(Payments to UMC Utrecht)

 

 

Speaker fees:

Gilead 2020 (payments to UMC Utrecht)

Vertex 2019 (payments to UMC Utrecht)

Research Output (76)

The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial

Terpstra Lotte C., Altenburg Josje, Mohamed Hoesein Firdaus A., Bronsveld Inez, Go Shirley, van Rijn Philip A.C., De Jong Pim A., Heijerman Harry G.M., Boersma Wim G. 28 Dec 2021, In: Respiratory Medicine. 192 , p. 1-6

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators

Muilwijk Danya, Bierlaagh Marlou, van Mourik Peter, Kraaijkamp Jasmijn, van der Meer Renske, van den Bor Rutger, Heijerman Harry, Eijkemans René, Beekman Jeffrey, van der Ent Kors 16 Dec 2021, In: Journal of Personalized Medicine. 11 , p. 1-12

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators

Aalbers Bente L, Bronsveld Inez, Hofland Regina W, Heijerman Harry G M 19 Aug 2021, In: Journal of Personalized Medicine. 11 7 p.

Breast development in a 7 year old girl with CF treated with ivacaftor:An indication for personalized dosing?

Jeyaratnam Joshena, van der Meer Renske, Berkers Gitte, Heijerman Harry Gm, Beekman Jeffrey M, van der Ent Cornelis K 23 Jun 2021, In: Journal of Cystic Fibrosis. 20 , p. e63-e66

CFTR Modulators:Does One Dose Fit All?

van der Meer Renske, Wilms Erik B, Heijerman Harry G M Jun 2021, In: Journal of Personalized Medicine. 11 12 p.

Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls

van der Meer Renske, Wilms Erik B, Sturm Richart, Heijerman Harry G M 15 May 2021, In: Journal of Cystic Fibrosis. 20 , p. e72-e76

Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation

Kristensen Maartje I, de Winter-de Groot Karin M, Berkers Gitte, Chu Mei Ling J N, Arp Kayleigh, Ghijsen Sophie, Heijerman Harry G M, Arets Hubertus G M, Majoor Christof J, Janssens Hettie M, van der Meer Renske, Bogaert Debby, van der Ent Cornelis K May 2021, In: Journal of Personalized Medicine. 11 , p. 1-9

Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation:A normal response to an abnormal situation

Spijkerman Roy, Bongers Suzanne H., Bindels Bas J.J., Tinnevelt Gerjen H., Giustarini Giulio, Jorritsma Nikita K.N., Buitenwerf Wiebe, van Spengler Daan E.J., Delemarre Eveline M., Nierkens Stefan, van Goor Harriët M.R., Jansen Jeroen J., Vrisekoop Nienke, Hietbrink Falco, Leenen Luke P.H., Kaasjager Karin A.H., Koenderman Leo, Nijdam Thomas M.P., van de Ven Nils L.M., Verhaegh Remi, Spanjaard Judith S., Verboeket Benjamin W., Laane Duco, van Wessem Karlijn, Mulder Eva, Heijerman Harry, Zabaleta Amely Daza, van den bos Frederiek, Stiphout Feikje, Rademaker Emma, Varkila Meri R.J., Mul Nikki d., Cremer Olaf L., Slooter Arjen, Limper Maarten, van Wijk Femke, Pandit Aridaman, Leavis Helen, Jukema Bernard N., Clark Chantal C., Barendrecht Arjan D., Seinen Cor W., Drost-Verhoef Sandra, Smits Simone, Parr Naomi M.J., Sebastian Sylvie A.E., van der Vries Erhard, Maas Coen, Haitjema Saskia, Hoefer Imo E., Jan 2021, In: Journal of Leukocyte Biology. 109 , p. 99-114 16 p.

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

Kos Renate, Brinkman Paul, Neerincx Anne H, Paff Tamara, Gerritsen Marije G, Lammers Ariana, Kraneveld Aletta D, Heijerman Harry G M, Janssens Hettie M, Davies Jane C, Majoor Christof J, Weersink Els J, Sterk Peter J, Haarman Eric G, Bos Lieuwe D, Maitland-van der Zee Anke H, 2021, In: Journal of Cystic Fibrosis. 21 , p. e28-e34

New Insights in Adherence and Survival in Myotonic Dystrophy Patients Using Home Mechanical Ventilation

Seijger Charlotte, Raaphorst Joost, Vonk Judith, van Engelen Baziel, Heijerman Harry, Stigter Nadine, Wijkstra Peter 2021, In: Respiration. 100 , p. 154-163 10 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not